Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

AGM Statement

30 Sep 2019 11:00

RNS Number : 0365O
Panoply Holdings PLC (The)
30 September 2019
 

30 September 2019

The Panoply Holdings PLC

("The Panoply", or the "Group")

AGM Statement

At the Company's Annual General Meeting, being held today at 11am, Mark Smith, Chairman of The Panoply, will make the following statement:

"As highlighted at the time of our preliminary results, the Board is pleased with the progress made across the Group, delivering first year results ahead of our expectations at the time of the IPO. In a short space of time we have created a genuine disruptor to the large IT service providers, helped further by our largest acquisition to date, FutureGov.

As well as the performance of our established businesses, we have been particularly pleased with the progress made in our early stage investments, Greenshoot Labs and human+, both of which have gained market traction ahead of original expectations. Greenshoot Labs is the start-up acquired in February which provides digital solutions using Artificial Intelligence and Conversational Interfaces, whilst human+ was launched from within the Group, also in February, to provide robotic process automation services. Despite being early stage, I am pleased to report that they have both recently signed up several notable contract wins, with Greenshoot Labs working with The Defence Science and Technology Laboratory, Brunel University and a global telecoms client, and human+ working with the Food Standards Agency, University College London and NHS Wales.

These contracts underpin our confidence in these offerings and their growing importance in the digital transformation market. As such, we have been increasing investment in both of these areas to maximise the opportunity and believe that they can both deliver significant revenue streams in future periods. We therefore reiterate the statement made at the time of our annual report that we expect profitability in the year to be largely second half weighted.

We continue to be excited about The Panoply's growth prospects and look forward to providing further updates to shareholders."

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Neil Shah

Luisa Orsini Baroni

 

 

 

Alma PR

(Financial PR)

Josh Royston

Susie Hudson

Kieran Breheny

panoply@almapr.co.uk

+44(0)203 405 0206

07780 901979

 

 

 

 

 

About The Panoply

 

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

 

More information is available at www.thepanoply.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMSEMFWWFUSESU
Date   Source Headline
17th Dec 20202:26 pmRNSHolding(s) in Company
17th Dec 20202:25 pmRNSHolding(s) in Company
11th Dec 20207:00 amRNSIssue of Shares/PDMR Dealing & TVR/SPA Amendments
10th Dec 20206:29 pmRNSSecondary sale of existing shares and PDMR dealing
10th Dec 20204:58 pmRNSProposed secondary sale of existing shares
2nd Dec 20204:42 pmRNSSecond Price Monitoring Extn
2nd Dec 20204:36 pmRNSPrice Monitoring Extension
2nd Dec 20202:06 pmRNSSecond Price Monitoring Extn
2nd Dec 20202:01 pmRNSPrice Monitoring Extension
2nd Dec 202011:06 amRNSSecond Price Monitoring Extn
2nd Dec 202011:01 amRNSPrice Monitoring Extension
1st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 202011:05 amRNSSecond Price Monitoring Extn
30th Nov 202011:00 amRNSPrice Monitoring Extension
30th Nov 20207:00 amRNSInterim Results
26th Nov 202011:05 amRNSSecond Price Monitoring Extn
26th Nov 202011:00 amRNSPrice Monitoring Extension
25th Nov 20204:40 pmRNSSecond Price Monitoring Extn
25th Nov 20204:35 pmRNSPrice Monitoring Extension
23rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20204:35 pmRNSPrice Monitoring Extension
23rd Nov 202011:05 amRNSSecond Price Monitoring Extn
23rd Nov 202011:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSNotice of Results
5th Nov 20207:00 amRNSIssue of Shares/PDMR dealing & total voting rights
19th Oct 20207:00 amRNSAppointment of Non-Executive Director
12th Oct 20207:00 amRNSTrading Update and Significant Contract Wins
6th Oct 20207:00 amRNSIssue of Shares/PDMR dealing & Total Voting Rights
5th Oct 20207:00 amRNSTotal Voting Rights
14th Sep 20201:30 pmRNSResult of AGM
14th Sep 20207:01 amRNSAppointment of Joint Broker
14th Sep 20207:00 amRNSAGM Statement
8th Sep 20207:02 amRNSIssue of Shares/PDMR dealing & total voting rights
8th Sep 20207:01 amRNSAmendment to Share Purchase Agreements
8th Sep 20207:00 amRNSAcquisition of Difrent
3rd Sep 20203:12 pmRNSTotal Voting Rights
20th Aug 20207:00 amRNSNotice of AGM and Posting of Report and Accounts
13th Aug 20207:00 amRNSIssue of Earnout Shares and Total Voting Rights
13th Aug 20207:00 amRNSSignificant Contract Wins
30th Jul 20207:00 amRNSPreliminary Results
21st Jul 20207:00 amRNSTrading Update and Notice of Results
17th Jun 20207:00 amRNSContract as part of major UK Government project
10th Jun 20207:00 amRNSAcquisition of Arthurly
26th May 20207:00 amRNSContract win, trading update and webinar
6th May 20204:37 pmRNSDirector/PDMR Shareholding
5th May 20207:00 amRNSGrant of Options under Company Share Option Plan
28th Apr 20207:00 amRNSTrading and COVID-19 Update
11th Mar 20207:00 amRNSAcquisition of Ameo
10th Feb 202010:22 amRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSPDMR dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.